Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
80.69
+0.32 (0.40%)
At close: Aug 8, 2025, 4:00 PM
80.59
-0.10 (-0.12%)
After-hours: Aug 8, 2025, 7:58 PM EDT

Paramount Global Statistics

Total Valuation

Merck & Co. has a market cap or net worth of $201.55 billion. The enterprise value is $228.33 billion.

Market Cap201.55B
Enterprise Value 228.33B

Important Dates

The last earnings date was Tuesday, July 29, 2025, before market open.

Earnings Date Jul 29, 2025
Ex-Dividend Date Sep 15, 2025

Share Statistics

Merck & Co. has 2.50 billion shares outstanding. The number of shares has decreased by -0.77% in one year.

Current Share Class 2.50B
Shares Outstanding 2.50B
Shares Change (YoY) -0.77%
Shares Change (QoQ) -0.71%
Owned by Insiders (%) 0.05%
Owned by Institutions (%) 80.38%
Float 2.49B

Valuation Ratios

The trailing PE ratio is 12.44 and the forward PE ratio is 8.81. Merck & Co.'s PEG ratio is 0.99.

PE Ratio 12.44
Forward PE 8.81
PS Ratio 3.20
Forward PS 3.00
PB Ratio 4.12
P/TBV Ratio 16.51
P/FCF Ratio 13.69
P/OCF Ratio 10.87
PEG Ratio 0.99
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.00, with an EV/FCF ratio of 15.51.

EV / Earnings 13.92
EV / Sales 3.59
EV / EBITDA 8.00
EV / EBIT 9.49
EV / FCF 15.51

Financial Position

The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.72.

Current Ratio 1.42
Quick Ratio 0.82
Debt / Equity 0.72
Debt / EBITDA 1.23
Debt / FCF 2.40
Interest Coverage 18.86

Financial Efficiency

Return on equity (ROE) is 35.42% and return on invested capital (ROIC) is 18.13%.

Return on Equity (ROE) 35.42%
Return on Assets (ROA) 13.07%
Return on Invested Capital (ROIC) 18.13%
Return on Capital Employed (ROCE) 26.30%
Revenue Per Employee $848,213
Profits Per Employee $218,747
Employee Count75,000
Asset Turnover 0.55
Inventory Turnover 2.20

Taxes

In the past 12 months, Merck & Co. has paid $2.74 billion in taxes.

Income Tax 2.74B
Effective Tax Rate 14.32%

Stock Price Statistics

The stock price has decreased by -28.27% in the last 52 weeks. The beta is 0.39, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y) 0.39
52-Week Price Change -28.27%
50-Day Moving Average 80.58
200-Day Moving Average 89.37
Relative Strength Index (RSI) 48.73
Average Volume (20 Days) 12,242,305

Short Selling Information

The latest short interest is 28.77 million, so 1.15% of the outstanding shares have been sold short.

Short Interest 28.77M
Short Previous Month 35.80M
Short % of Shares Out 1.15%
Short % of Float 1.15%
Short Ratio (days to cover) 1.61

Income Statement

In the last 12 months, Merck & Co. had revenue of $63.62 billion and earned $16.41 billion in profits. Earnings per share was $6.49.

Revenue63.62B
Gross Profit 49.25B
Operating Income 24.06B
Pretax Income n/a
Net Income 16.41B
EBITDA 28.54B
EBIT 24.06B
Earnings Per Share (EPS) $6.49
Full Income Statement

Balance Sheet

The company has $8.62 billion in cash and $35.40 billion in debt, giving a net cash position of -$26.78 billion or -$10.72 per share.

Cash & Cash Equivalents 8.62B
Total Debt 35.40B
Net Cash -26.78B
Net Cash Per Share -$10.72
Equity (Book Value) 49.06B
Book Value Per Share 19.57
Working Capital 11.03B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $18.53 billion and capital expenditures -$3.81 billion, giving a free cash flow of $14.72 billion.

Operating Cash Flow 18.53B
Capital Expenditures -3.81B
Free Cash Flow 14.72B
FCF Per Share $5.89
Full Cash Flow Statement

Margins

Gross margin is 77.41%, with operating and profit margins of 37.82% and 25.79%.

Gross Margin 77.41%
Operating Margin 37.82%
Pretax Margin 30.12%
Profit Margin 25.79%
EBITDA Margin 44.86%
EBIT Margin 37.82%
FCF Margin 23.14%

Dividends & Yields

This stock pays an annual dividend of $3.24, which amounts to a dividend yield of 4.02%.

Dividend Per Share $3.24
Dividend Yield 4.02%
Dividend Growth (YoY) 5.19%
Years of Dividend Growth 14
Payout Ratio 49.96%
Buyback Yield 0.77%
Shareholder Yield 4.78%
Earnings Yield 8.14%
FCF Yield 7.30%
Dividend Details

Analyst Forecast

The average price target for Merck & Co. is $111.14, which is 37.74% higher than the current price. The consensus rating is "Buy".

Price Target $111.14
Price Target Difference 37.74%
Analyst Consensus Buy
Analyst Count 15
Revenue Growth Forecast (5Y) 2.35%
EPS Growth Forecast (5Y) 8.65%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on February 17, 1999. It was a forward split with a ratio of 2:1.

Last Split Date Feb 17, 1999
Split Type Forward
Split Ratio 2:1

Scores

Merck & Co. has an Altman Z-Score of 4.34 and a Piotroski F-Score of 6.

Altman Z-Score 4.34
Piotroski F-Score 6